SCHEMBL172750

SCHEMBL172750

Cc1cc(N(C)C)ccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
TP53 P04637 1/20 0.52
PDE10A Q9Y233 1/20 0.48
MAPT P10636 3/20 0.47
ESR1 P03372 8/20 0.46
ALDH1A1 P00352 6/20 0.46
ESR2 Q92731 6/20 0.46
TSHR P16473 3/20 0.46
HSD17B10 Q99714 4/20 0.46
ALOX15 P16050 3/20 0.46
AR P10275 3/20 0.43
KDM4E B2RXH2 3/20 0.42
HPGD P15428 3/20 0.42
PKM P14618 2/20 0.42
MAPK1 P28482 2/20 0.42
HIF1A Q16665 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11671106 0.83 TP53 (0.54) TDP1TP53PDE10AMAPTESR1
SCHEMBL1598733 0.81 TSHR (0.48) TDP1MAPTALDH1A1TSHRHSD17B10
SCHEMBL25540950 0.80 ALDH1A1 (0.59) TDP1MAPTALDH1A1TSHRHSD17B10
SCHEMBL15894584 0.79 ESR1 (0.47) TDP1TP53PDE10AMAPTESR1
SCHEMBL346399 0.77 ALDH1A1 (0.53) TDP1TP53MAPTALDH1A1TSHR
SCHEMBL3992952 0.77 HSP90AA1 (0.49) TDP1TP53PDE10AMAPTESR1
SCHEMBL9230516 0.76 APP (0.50) TDP1TP53MAPTALDH1A1TSHR
SCHEMBL10485810 0.76 S100B (0.60) TDP1TP53MAPTESR1ALDH1A1
SCHEMBL30966777 0.75 ALDH1A1 (0.50) TDP1TP53MAPTALDH1A1TSHR
SCHEMBL13990194 0.75 ALDH1A1 (0.50) TDP1TP53MAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112194767-B Benzoxazine resin containing zwitter-ion group and preparation method and application thereof 山东大学 2021-06-29 CN claimed
US-5691122-A REDOX SYSTEMS, COCATALYSTS, REHALOGENATION EASTMAN KODAK COMPANY (US) 1997-11-25 US claimed
US-5656416-A REVERSE REDOX COUPLE; SYNERGISTIC BLEACHING EASTMAN KODAK COMPANY (US) 1997-08-12 US claimed
US-9145410-B2 Pyrazolopyridines and analogs thereof 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-09-29 US disclosed
US-8263657-B2 Blocking neurokinins; using a benzene compound containing hydroxy or acetoxy group; antiinflammatory agents INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2012-09-11 US disclosed
US-20120121651-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2012-05-17 US disclosed
EP-1352650-B1 INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES INST MED MOLECULAR DESIGN INC (JP) 2012-03-07 EP disclosed
US-8097759-B2 Inflammatory cytokine release inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2012-01-17 US disclosed
US-7879849-B2 such as 1-(2-Methylpropyl)-2-propyl-2H-pyrazolo[3,4-c]quinolin-4-amine, used as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of viral and neoplastic diseases 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-02-01 US disclosed
US-20100274051-A1 INFLAMMATORY CYTOKINE RELEASE INHIBITOR INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2010-10-28 US disclosed
US-20090318435-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF 3M INNOVATIVE PROPERTIES COMPANY 2009-12-24 US disclosed
US-4840879-A COLORED LATENT IMAGE IS REACTION PRODUCT OF COUPLER AND AROMATIC PRIMARY AMINO COLOR DEVELOPER KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1989-06-20 US disclosed
EP-0251419-B1 FUEL COMPOSITION AND ADDITIVE CONCENTRATES, AND THEIR USE IN INHIBITING ENGINE COKING ETHYL CORPORATION (US) 1989-05-31 EP disclosed
EP-0113666-A1 Hydroxybenzylcyclopentadienes and derivatives thereof The B.F. GOODRICH Company (US) 1984-07-18 EP disclosed
EP-0089101-A2 Direct positive image-forming process KONICA CORPORATION (JP) 1983-09-21 EP disclosed
EP-0040741-B1 PROCESS FOR THE PREPARATION OF CHLOROFORMIC-ACID ARYL ESTERS BAYER AG (DE) 1983-06-08 EP disclosed
US-4366102-A Process for the preparation of chloroformic acid aryl esters BAYER AKTIENGESELLSCHAFT (DE) 1982-12-28 US disclosed
EP-0040741-A1 Process for the preparation of chloroformic-acid aryl esters BAYER AG (DE) 1981-12-02 EP disclosed
US-3994724-A SUBSTITUTED ANILINE PHOTOCONDUCTOR SCOTT PAPER COMPANY (US) 1976-11-30 US disclosed
US-3986991-A EPOXIDES, TERTIARY AMINE, GLYCINE SALT THE UPJOHN COMPANY (US) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100274051-A1 INFLAMMATORY CYTOKINE RELEASE INHIBITOR IL1B, NFKBIA, IL1A TDP1 4412/4885TP53 3038/4885PDE10A 2242/4885
US-20120121651-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF IL4, IL4I1, IL2 TDP1 711/4885TP53 35/4885PDE10A 1548/4885
US-20090318435-A1 PYRAZOLOPYRIDINES AND ANALOGS THEREOF IL4, IL2, IL4I1 TDP1 1133/4885TP53 46/4885PDE10A 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.